Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765953674> ?p ?o ?g. }
- W2765953674 abstract "Abstract Background Plasmodium falciparum prevalence ( Pf PR) is a widely used metric for assessing malaria transmission intensity. This study was carried out concurrently with the RTS,S/AS01 candidate malaria vaccine Phase III trial and estimated Pf PR over ≤ 4 standardized cross-sectional surveys. Methods This epidemiology study (NCT01190202) was conducted in 8 sites from 6 countries (Burkina Faso, Gabon, Ghana, Kenya, Malawi, and Tanzania), between March 2011 and December 2013. Participants were enrolled in a 2:1:1 ratio according to age category: 6 months–4 years, 5–19 years, and ≥ 20 years, respectively, per year and per centre. All sites carried out surveys 1–3 while survey 4 was conducted only in 3 sites. Surveys were usually performed during the peak malaria parasite transmission season, in one home visit, when medical history and malaria risk factors/prevention measures were collected, and a blood sample taken for rapid diagnostic test, microscopy, and haemoglobin measurement. Pf PR was estimated by site and age category. Results Overall, 6401 (survey 1), 6411 (survey 2), 6400 (survey 3), and 2399 (survey 4) individuals were included in the analyses. In the 6 months–4 years age group, the lowest prevalence (assessed using microscopy) was observed in 2 Tanzanian centres (4.6% for Korogwe and 9.95% for Bagamoyo) and Lambaréné, Gabon (6.0%), while the highest PfPR was recorded for Nanoro, Burkina Faso (52.5%). PfPR significantly decreased over the 3 years in Agogo (Ghana), Kombewa (Kenya), Lilongwe (Malawi), and Bagamoyo (Tanzania), and a trend for increased Pf PR was observed over the 4 surveys for Kintampo, Ghana. Over the 4 surveys, for all sites, Pf PR was predominantly higher in the 5–19 years group than in the other age categories. Occurrence of fever and anaemia was associated with high P. falciparum parasitaemia. Univariate analyses showed a significant association of anti-malarial treatment in 4 surveys (odds ratios [ORs]: 0.52, 0.52, 0.68, 0.41) and bed net use in 2 surveys (ORs: 0.63, 0.68, 1.03, 1.78) with lower risk of malaria infection. Conclusion Local Pf PR differed substantially between sites and age groups. In children 6 months–4 years old, a significant decrease in prevalence over the 3 years was observed in 4 out of the 8 study sites. Trial registration Clinical Trials.gov identifier: NCT01190202:NCT. GSK Study ID numbers: 114001" @default.
- W2765953674 created "2017-11-10" @default.
- W2765953674 creator A5004352759 @default.
- W2765953674 creator A5004637117 @default.
- W2765953674 creator A5006633326 @default.
- W2765953674 creator A5008867801 @default.
- W2765953674 creator A5010966506 @default.
- W2765953674 creator A5011187406 @default.
- W2765953674 creator A5012745143 @default.
- W2765953674 creator A5016433756 @default.
- W2765953674 creator A5019294499 @default.
- W2765953674 creator A5019569376 @default.
- W2765953674 creator A5021913918 @default.
- W2765953674 creator A5024909046 @default.
- W2765953674 creator A5026563930 @default.
- W2765953674 creator A5027270405 @default.
- W2765953674 creator A5027430222 @default.
- W2765953674 creator A5027507501 @default.
- W2765953674 creator A5030213317 @default.
- W2765953674 creator A5030494745 @default.
- W2765953674 creator A5032249049 @default.
- W2765953674 creator A5032686679 @default.
- W2765953674 creator A5033754121 @default.
- W2765953674 creator A5034957435 @default.
- W2765953674 creator A5035845606 @default.
- W2765953674 creator A5035892502 @default.
- W2765953674 creator A5037076197 @default.
- W2765953674 creator A5038886321 @default.
- W2765953674 creator A5040926542 @default.
- W2765953674 creator A5041065507 @default.
- W2765953674 creator A5041726477 @default.
- W2765953674 creator A5043099725 @default.
- W2765953674 creator A5043369631 @default.
- W2765953674 creator A5043850672 @default.
- W2765953674 creator A5044590172 @default.
- W2765953674 creator A5046943317 @default.
- W2765953674 creator A5052096911 @default.
- W2765953674 creator A5058814588 @default.
- W2765953674 creator A5061100424 @default.
- W2765953674 creator A5069437397 @default.
- W2765953674 creator A5069843611 @default.
- W2765953674 creator A5070325419 @default.
- W2765953674 creator A5074056742 @default.
- W2765953674 creator A5087449157 @default.
- W2765953674 creator A5088720377 @default.
- W2765953674 creator A5089322310 @default.
- W2765953674 creator A5089349639 @default.
- W2765953674 creator A5089721938 @default.
- W2765953674 creator A5090096797 @default.
- W2765953674 creator A5090444000 @default.
- W2765953674 creator A5091687199 @default.
- W2765953674 creator A5091869484 @default.
- W2765953674 date "2017-10-27" @default.
- W2765953674 modified "2023-10-16" @default.
- W2765953674 title "Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries" @default.
- W2765953674 cites W1584480503 @default.
- W2765953674 cites W1729017034 @default.
- W2765953674 cites W1755904813 @default.
- W2765953674 cites W1999990093 @default.
- W2765953674 cites W2004839655 @default.
- W2765953674 cites W2012117556 @default.
- W2765953674 cites W2016916843 @default.
- W2765953674 cites W2050282436 @default.
- W2765953674 cites W2050811145 @default.
- W2765953674 cites W2058960648 @default.
- W2765953674 cites W2072984816 @default.
- W2765953674 cites W2081354450 @default.
- W2765953674 cites W2082465697 @default.
- W2765953674 cites W2092923243 @default.
- W2765953674 cites W2094077008 @default.
- W2765953674 cites W2108476551 @default.
- W2765953674 cites W2108522763 @default.
- W2765953674 cites W2112338101 @default.
- W2765953674 cites W2112980231 @default.
- W2765953674 cites W2117914570 @default.
- W2765953674 cites W2132382696 @default.
- W2765953674 cites W2135490630 @default.
- W2765953674 cites W2135734379 @default.
- W2765953674 cites W2138132137 @default.
- W2765953674 cites W2139099461 @default.
- W2765953674 cites W2139604181 @default.
- W2765953674 cites W2143229710 @default.
- W2765953674 cites W2153256977 @default.
- W2765953674 cites W2153642463 @default.
- W2765953674 cites W2157937240 @default.
- W2765953674 cites W2158489761 @default.
- W2765953674 cites W2159034898 @default.
- W2765953674 cites W2163697153 @default.
- W2765953674 cites W2166241739 @default.
- W2765953674 cites W2178948366 @default.
- W2765953674 cites W2244674613 @default.
- W2765953674 cites W2414725590 @default.
- W2765953674 cites W2417418506 @default.
- W2765953674 cites W2468126155 @default.
- W2765953674 cites W2473814412 @default.
- W2765953674 cites W2554538570 @default.
- W2765953674 cites W2556906649 @default.
- W2765953674 cites W2572502326 @default.
- W2765953674 cites W2587008904 @default.
- W2765953674 cites W4211099777 @default.